PlainRecalls
FDA Drug Moderate Class II Terminated

Nevirapine Extended Release Tablets, 400 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd. Verna Goa, India, Manufactured for: Cipla USA Inc. 9100 S Dadeland Blvd., Suite 1500 Miami, FL 33156, NDC 69097-403-02

Reported: December 26, 2018 Initiated: December 14, 2018 #D-0382-2019

Product Description

Nevirapine Extended Release Tablets, 400 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd. Verna Goa, India, Manufactured for: Cipla USA Inc. 9100 S Dadeland Blvd., Suite 1500 Miami, FL 33156, NDC 69097-403-02

Reason for Recall

Failed Dissolution Specifications.

Details

Recalling Firm
Cipla Limited
Units Affected
4800 bottles
Distribution
Nationwide within the United States
Location
Vasco Da Gama

Frequently Asked Questions

What product was recalled?
Nevirapine Extended Release Tablets, 400 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd. Verna Goa, India, Manufactured for: Cipla USA Inc. 9100 S Dadeland Blvd., Suite 1500 Miami, FL 33156, NDC 69097-403-02. Recalled by Cipla Limited. Units affected: 4800 bottles.
Why was this product recalled?
Failed Dissolution Specifications.
Which agency issued this recall?
This recall was issued by the FDA Drug on December 26, 2018. Severity: Moderate. Recall number: D-0382-2019.